Manulife Reports Second Quarter 2024 Results
TSX/NYSE/PSE: MFC SEHK: 945 C$ unless otherwise stated
TORONTO, Aug. 7, 2024 /PRNewswire/ - Manulife Financial Corporation ("Manulife" or the "Company") reported its second quarter results for the period ended June 30, 2024, delivering positive momentum in core earnings, new business and book value growth.
Key highlights for the second quarter of 2024 ("2Q24") include:
- Core earnings1 of $1.7 billion, up 6% on a constant exchange rate basis2 from the second quarter of 2023 ("2Q23")
- Net income attributed to shareholders of $1.0 billion, in-line with 2Q23
- Core EPS3 of $0.91, up 9%2 from 2Q23. EPS of $0.52, up 1%2 from 2Q23
- Excluding the impact of Global Minimum Taxes ("GMT")4, core EPS3 was $0.94, up 12%2 from 2Q23
- Core ROE3 of 15.7% and ROE of 9.0%
- LICAT ratio5 of 139%
- APE sales up 17%6, new business CSM up 6%2 and new business value ("NBV") up 23%6 from 2Q237
- Global Wealth and Asset Management net inflows6 of $0.1 billion, down from $2.2 billion in 2Q23
- Bought back 31 million, or $1.1 billion worth of common shares as of July 31, 2024, and plan to buy back the maximum 90 million shares through the current NCIB, representing a capital return of more than $3 billion8
"At our Investor Day in June, we communicated our goals of raising the bar on our financial targets. We are pleased to demonstrate continued positive momentum in the second quarter, with core EPS and new business value growth of 9% and 23%, respectively. As part of our transformation toward a higher return and lower risk business, we are proud to have closed the largest UL reinsurance transaction in Canada9 and the acquisition of CQS. Momentum also continued in our growth engines, with Asia delivering strong growth in core earnings, new business CSM and new business value margin6 year-over-year, and Global WAM delivering positive net flows and an improved core EBITDA margin3. We continue to demonstrate that we have a strong track record of execution, and I am confident about the future and our ability to execute against our strategy and deliver value to our shareholders."
— Roy Gori, Manulife President & Chief Executive Officer
"Adjusted book value per common share3 continued to grow and was up 15% year-over-year. Core ROE of 15.7% in the second quarter reflected strong profitability despite the impact of GMT. Our capital position remained strong with a LICAT ratio of 139%. We have repurchased more than 31 million common shares and are planning on buying back the full 90 million shares under our current program, representing a capital return of over $3 billion."
— Colin Simpson, Manulife Chief Financial Officer
Results at a Glance
($ millions, unless otherwise stated) | Quarterly Results | YTD Results | |||||||||
2Q24 | 2Q23 | Change2,6 | 2024 | 2023 | Change | ||||||
Net income attributed to shareholders | $ | 1,042 | $ | 1,025 | (1) % | $ | 1,908 | $ | 2,431 | (22) % | |
Core earnings | $ | 1,737 | $ | 1,637 | 6 % | $ | 3,491 | $ | 3,168 | 11 % | |
EPS ($) | $ | 0.52 | $ | 0.50 | 1 % | $ | 0.97 | $ | 1.23 | (21) % | |
Core EPS ($) | $ | 0.91 | $ | 0.83 | 9 % | $ | 1.85 | $ | 1.63 | 14 % | |
ROE | 9.0 % | 9.3 % | -0.3 pps | 8.5 % | 11.4 % | -2.9 pps | |||||
Core ROE | 15.7 % | 15.5 % | 0.2 pps | 16.2 % | 15.2 % | 1.0 pps | |||||
Book value per common share ($) | $ | 23.71 | $ | 21.30 | 11 % | $ | 23.71 | $ | 21.30 | 11 % | |
Adjusted BV per common share ($) | $ | 33.96 | $ | 29.42 | 15 % | $ | 33.96 | $ | 29.42 | 15 % | |
Financial leverage ratio (%)3 | 24.6 % | 25.8 % | -1.2 pps | 24.6 % | 25.8 % | -1.2 pps | |||||
APE sales | $ | 1,907 | $ | 1,633 | 17 % | $ | 3,790 | $ | 3,233 | 19 % | |
New business CSM | $ | 628 | $ | 592 | 6 % | $ | 1,286 | $ | 1,034 | 25 % | |
NBV | $ | 723 | $ | 585 | 23 % | $ | 1,392 | $ | 1,094 | 28 % | |
Global WAM net flows ($ billions) | $ | 0.1 | $ | 2.2 | (96) % | $ | 6.8 | $ | 6.6 | 4 % | |
Results by Segment
($ millions, unless otherwise stated) | Quarterly Results | YTD Results | |||||||||||
2Q24 | 2Q23 | Change6 | 2024 | 2023 | Change | ||||||||
Asia (US$) | |||||||||||||
Net income attributed to shareholders | $ | 424 | $ | 96 | 289 % | $ | 694 | $ | 480 | 41 % | |||
Core earnings | 472 | 353 | 40 % | 960 | 714 | 40 % | |||||||
APE sales | 920 | 879 | 7 % | 1,870 | 1,747 | 10 % | |||||||
New business CSM | 349 | 323 | 10 % | 713 | 545 | 34 % | |||||||
NBV | 370 | 315 | 19 % | 713 | 590 | 23 % | |||||||
Canada | |||||||||||||
Net income attributed to shareholders | $ | 79 | $ | 227 | (65) % | $ | 352 | $ | 536 | (34) % | |||
Core earnings | 402 | 374 | 7 % | 766 | 727 | 5 % | |||||||
APE sales | 520 | 322 | 61 % | 970 | 615 | 58 % | |||||||
New business CSM | 76 | 57 | 33 % | 146 | 103 | 42 % | |||||||
NBV | 159 | 106 | 50 % | 316 | 198 | 60 % | |||||||
U.S. (US$) | |||||||||||||
Net income attributed to shareholders | $ | 98 | $ | 136 | (28) % | $ | 18 | $ | 274 | (93) % | |||
Core earnings | 303 | 341 | (11) % | 638 | 626 | 2 % | |||||||
APE sales | 93 | 97 | (4) % | 206 | 196 | 5 % | |||||||
New business CSM | 54 | 77 | (30) % | 126 | 147 | (14) % | |||||||
NBV | 41 | 40 | 3 % | 78 | 74 | 5 % | |||||||
Global WAM | |||||||||||||
Net income attributed to shareholders | $ | 350 | $ | 317 | 9 % | $ | 715 | $ | 614 | 16 % | |||
Core earnings | 399 | 320 | 23 % | 756 | 607 | 24 % | |||||||
Gross flows ($ billions)6 | 41.4 | 35.2 | 17 % | 86.9 | 74.0 | 18 % | |||||||
Average AUMA ($ billions)6 | 933.1 | 814.9 | 13 % | 916.7 | 809.5 | 13 % | |||||||
Core EBITDA margin (%) | 26.3 % | 24.6 % | 170 bps | 25.9 % | 23.5 % | 240 bps | |||||||
Strategic Highlights
We are expanding our customer reach through strategic partnerships and new product offerings
In Global WAM, we completed the acquisition of CQS, the U.K.-based multi-sector alternative credit manager, which we have co-branded as Manulife | CQS Investment Management and have leveraged these expanded capabilities to launch the John Hancock Multi Asset Credit Fund in U.S. Retail. This fund is a strong addition to our growing lineup of liquid and semi-liquid alternative offerings and our larger credit franchise.
In the U.S., we announced a strategic partnership with Annexus – one of the nation's leading independent product design and distribution companies – to expand our portfolio of indexed account offerings and reach a wider market with our Protection Indexed Universal Life solution.
We are deploying Generative AI and delivering on our Digital, Customer Leader strategic priority
In Asia, we enhanced agent-customer interactions through the launch of an innovative Generative AI agent sales tool in Singapore that enables our agents to automatically create personalized engagement strategies to offer customers the right solutions at the right time based on their needs, preferences, demographic data, and transaction histories.
In Global WAM, we piloted our Manulife Mandatory Provident Fund ("MPF") Robo-Advisor in Hong Kong Retirement, a new portal that aims to provide automated portfolio insights and personalized investment tips to our MPF members. This initiative is part of our ongoing commitment to enhancing customer experiences in MPF investment management through digital innovation and strengthening member education.
In Canada, we enhanced our Manulife mobile app for group benefits members by adding mental health features and live support. These services were added in alliance with TELUS Health10 and provide eligible members and their families immediate, personal assistance in navigating the healthcare system to help them understand the types of support available.
In the U.S., we deployed a Generative AI knowledge management chatbot and automated call summarization for our customer service representatives within our Annuities contact center, contributing to an immediate improvement to average handle time. This initiative is part of our continuing efforts to enhance customer experience and streamline processes.
We are helping our customers live longer, healthier, and better lives
In the U.S., we advanced our commitment to provide preventative health screenings to customers and further differentiated our solutions by becoming the first U.S. life insurer to offer discounted and prioritized access to Prenuvo – a whole body MRI scan for the early detection of cancer and other diseases – to eligible John Hancock Vitality members.
In Canada, we released our 2023 Wellness Report which highlighted health trends and challenges that affected Canadian employees of our group benefits plan sponsors. This report supports our plan sponsors with valuable, data-driven insights so they can ensure their plan designs are targeting areas of highest concern to help drive better health outcomes for plan members.
Strong earnings results reflect continued business growth, more than offsetting the impact of GMT and reinsurance transactions11
Core earnings of $1.7 billion in 2Q24, up 6% from 2Q23
Our positive momentum continued in 2Q24 with a 6% increase year-over-year, as strong business growth more than offset the impact of GMT.
- Asia core earnings were up 40%, benefitting from continued business growth momentum and updates to actuarial methods and assumptions in the second half of 2023.
- Global WAM core earnings grew 23%, driven by higher fee income from favourable market impacts and positive net flows, and a favourable tax true-up.
- In Canada, strong growth in Group Insurance and favourable net insurance experience contributed to a 7% growth in 2Q24 core earnings.
- In the U.S., adverse net insurance experience and foregone core earnings from the long-term care reinsurance transaction announced in December 2023 resulted in an 11% decrease in 2Q24 core earnings.
- In Corporate and Other, core earnings decreased $138 million, reflecting the impact of GMT, higher interest on allocated capital to operating segments and higher workforce-related expenses.
Net Income attributed to shareholders of $1.0 billion in 2Q24, consistent with 2Q23
Net income was in-line compared with 2Q23, as improved market experience and core earnings growth were offset by a $0.3 billion realized loss due to the sale of debt instruments related to the RGA reinsurance transaction. This realized loss was broadly offset by an associated change in other comprehensive income, resulting in a neutral impact to book value. This, along with lower-than-expected returns on alternative long-duration assets mainly related to private equity and real estate investments, contributed to a net charge in market experience in 2Q24.
Continued momentum in new insurance business results and positive net flows in Global WAM
We delivered another quarter of strong new business growth in our insurance businesses with APE sales and NBV hitting record levels in 2Q24, demonstrating the strength and benefits of our diversified portfolio. Overall, our APE sales, new business CSM and NBV increased year-over-year by 17%, 6% and 23%, respectively.
- Asia continued to generate positive momentum and grew APE sales, new business CSM and NBV by 7%, 10% and 19%, respectively, reflecting higher sales volumes in Japan and Hong Kong in 2Q24. The year-over-year improvement of 3.4 percentage points in NBV margin reflected our pricing discipline and changes in business mix.
- Canada delivered excellent growth and record level NBV this quarter. Compared with 2Q23, APE sales and NBV increased 61% and 50%, respectively, driven by higher sales volumes in all business units, led by a large-case Group Insurance sale. New business CSM was up 33% driven by margin expansion in Individual Insurance and higher sales volumes in segregated fund products.
- In the U.S., APE sales decreased 4% year-over-year with a shift in product mix, while NBV was up 3%. New business CSM decreased 30% due to change in product mix and the impact of higher interest rates.
Global WAM net inflows of $0.1 billion in 2Q24, mainly reflecting the strength in our Institutional business, offset by outflows in our Retirement business. Compared with 2Q23, net inflows was $2.1 billion lower.
- Retirement net outflows of $1.3 billion in 2Q24 compared with net inflows of $0.7 billion in 2Q23, as higher member contributions were more than offset by increased member withdrawals and a large-case retirement plan redemption in the U.S.
- Retail net outflows of $0.1 billion in 2Q24 were in line with 2Q23, as increased demand for investment products amid equity market recovery and improved investor sentiment was offset by higher redemptions.
- Institutional Asset Management net inflows of $1.4 billion in 2Q24 compared with net inflows of $1.6 billion in 2Q23 as net inflows from CQS were more than offset by higher redemptions in fixed income mandates and lower sales in alternative mandates.
Organic Contractual Service Margin ("CSM") growth contributing to higher CSM balance
CSM12 was $20,758 million as at June 30, 2024
CSM increased $318 million compared with December 31, 2023. Organic CSM movement contributed $453 million of the increase in the first half of 2024, primarily driven by the impact of new business and interest accretion, partially offset by amortization recognized in core earnings and adverse insurance experience. Inorganic CSM movement was a decrease of $135 million for the same period, primarily driven by the impact of reinsurance transactions, partially offset by favourable impacts of changes in foreign currency exchange rates and equity market performance. Post-tax CSM net of NCI1 was $18,290 million as at June 30, 2024.
______________________________ | |
1 | Core earnings and post-tax contractual service margin net of NCI ("post-tax CSM net of NCI") are non-GAAP financial measures. For more information on non-GAAP and other financial measures, see "Non-GAAP and other financial measures" below and in our 2Q24 Management's Discussion and Analysis ("2Q24 MD&A"). |
2 | Percentage growth / declines in core earnings, diluted core earnings per common share ("core EPS"), diluted earnings (loss) per share ("EPS"), core EPS excluding the impact of GMT, new business contractual service margin net of NCI ("new business CSM"), and net income attributed to shareholders are stated on a constant exchange rate basis and are non-GAAP ratios. |
3 | Core EPS, core EPS excluding the impact of GMT, core ROE, core EBITDA margin, adjusted book value per common share ("adjusted BV per common share") and financial leverage ratio are non-GAAP ratios. |
4 | On June 20, 2024, Canada enacted the Global Minimum Tax Act. The impact was reflected in Corporate & Other in situations where GMT was not substantively enacted in local jurisdictions where we operate as of June 30, 2024. |
5 | Life Insurance Capital Adequacy Test ("LICAT") ratio of The Manufacturers Life Insurance Company ("MLI") as at June 30, 2024. LICAT ratio is disclosed under the Office of the Superintendent of Financial Institutions Canada's ("OSFI's") Life Insurance Capital Adequacy Test Public Disclosure Requirements guideline. |
6 | For more information on annualized premium equivalent ("APE") sales, NBV, Global Wealth and Asset Management ("Global WAM") net flows, new business value margin ("NBV margin"), gross flows, and average asset under management and administration ("average AUMA"), see "Non-GAAP and other financial measures" below. In this news release, percentage growth/decline in APE sales, NBV, net flows, gross flows and average AUMA are stated on a constant exchange rate basis. |
7 | Refer to "Results at a Glance" for 2Q24 and 2Q23 results. |
8 | NCIB stands for Normal Course Issuer Bid. The estimated capital return is calculated based on MFC share price as of market close on July 31, 2024. See "Caution regarding forward-looking statements" below. |
9 | Also referred to as the RGA reinsurance transaction. |
10 | Telus Health (Canada) Ltd. |
11 | See section A1 "Profitability" in our 2Q24 MD&A for more information on notable items attributable to core earnings and net income attributed to shareholders. |
12 | Net of non-controlling interests. |
Quarterly Results Conference Call
Manulife will host a conference call and live webcast on its second quarter 2024 results on August 8, 2024, at 8:00 a.m. (ET). To access the conference call, dial 1-800-806-5484 or 1-416-340-2217 (Passcode: 6941503#). Please call in 15 minutes before the scheduled start time. You will be required to provide your name and organization to the operator. You may access the webcast at manulife.com/en/investors/results-and-reports.
The archived webcast will be available following the call at the same URL as above. A replay of the call will also be available until September 7, 2024, by dialing 1-800-408-3053 or 1-905-694-9451 (Passcode: 3700999#).
The Second Quarter 2024 Statistical Information Package is also available on the Manulife website at www.manulife.com/en/investors/results-and-reports.
This earnings news release should be read in conjunction with the Company's Second Quarter 2024 Report to Shareholders, including our unaudited interim Consolidated Financial Statements for the three and six months ended June 30, 2024, prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board, which is available on our website at https://www.manulife.com/en/investors/results-and-reports.html. The Company's 2Q24 MD&A and additional information relating to the Company is available on the SEDAR+ website at http://www.sedarplus.ca and on the U.S. Securities and Exchange Commission's ("SEC") website at http://www.sec.gov.
Any information contained in, or otherwise accessible through, websites mentioned in this news release does not form a part of this document unless it is expressly incorporated by reference.
Earnings
The following table presents net income attributed to shareholders, consisting of core earnings and details of the items excluded from core earnings:
Quarterly Results | YTD Results | ||||||
($ millions) | 2Q24 | 1Q24 | 2Q23 | 2024 | 2023 | ||
Core earnings | |||||||
Asia | $ 647 | $ 657 | $ 473 | $ 1,304 | $ 962 | ||
Canada | 402 | 364 | 374 | 766 | 727 | ||
U.S. | 415 | 452 | 458 | 867 | 843 | ||
Global Wealth and Asset Management | 399 | 357 | 320 | 756 | 607 | ||
Corporate and Other | (126) | (76) | 12 | (202) | 29 | ||
Total core earnings | $ 1,737 | $ 1,754 | $ 1,637 | $ 3,491 | $ 3,168 | ||
Items excluded from core earnings: Market experience gains (losses) | (665) | (779) | (570) | (1,444) | (635) | ||
Change in actuarial methods and assumptions that flow directly through income | - | - | - | - | - | ||
Restructuring charge | - | - | - | - | - | ||
Reinsurance transactions, tax-related items and other | (30) | (109) | (42) | (139) | (102) | ||
Net income attributed to shareholders | $ 1,042 | $ 866 | $ 1,025 | $ 1,908 | $ 2,431 | ||
Non-GAAP and other financial measures
The Company prepares its Consolidated Financial Statements in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board. We use a number of non-GAAP and other financial measures to evaluate overall performance and to assess each of our businesses. This section includes information required by National Instrument 52-112 – Non-GAAP and Other Financial Measures Disclosure in respect of "specified financial measures" (as defined therein).
Non-GAAP financial measures include core earnings (loss); core earnings available to common shareholders; core earnings before interest, taxes, depreciation and amortization ("core EBITDA"); core revenue; adjusted book value; post-tax contractual service margin; and post-tax contractual service margin net of NCI ("post-tax CSM net of NCI"). In addition, non-GAAP financial measures include the following stated on a constant exchange rate ("CER") basis: any of the foregoing non-GAAP financial measures; net income attributed to shareholders; and common shareholders' net income.
Non-GAAP ratios include core return on common shareholders' equity ("core ROE"); diluted core earnings per common share ("core EPS"); core EPS excluding the impact of Global Minimum Taxes ("GMT"); adjusted book value per common share; financial leverage ratio; core EBITDA margin; and percentage growth/decline on a constant exchange rate basis in any of the above non-GAAP financial measures and non-GAAP ratios; net income attributed to shareholders; diluted earnings per common share ("EPS"); and new business CSM.
Other specified financial measures include NBV; APE sales; gross flows; net flows; average assets under management and administration ("average AUMA"); new business value margin ("NBV margin"); and percentage growth/decline in these foregoing specified financial measures. In addition, explanations of the components of the CSM movement, other than the new business CSM were provided in the 2Q24 MD&A.
Non-GAAP financial measures and non-GAAP ratios are not standardized financial measures under GAAP and, therefore, might not be comparable to similar financial measures disclosed by other issuers. Therefore, they should not be considered in isolation or as a substitute for any other financial information prepared in accordance with GAAP. For more information on non-GAAP financial measures, including those referred to above, see the section "Non-GAAP and other financial measures" in our 2Q24 MD&A, which is incorporated by reference.
Reconciliation of core earnings to net income attributed to shareholders – 2Q24
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
2Q24 | ||||||||
Asia | Canada | U.S. | Global | Corporate | Total | |||
Income (loss) before income taxes | $ 763 | $ 141 | $ 156 | $ 383 | $ (59) | $ 1,384 | ||
Income tax (expenses) recoveries | ||||||||
Core earnings | (64) | (107) | (95) | (46) | (8) | (320) | ||
Items excluded from core earnings | (51) | 68 | 74 | 14 | (37) | 68 | ||
Income tax (expenses) recoveries | (115) | (39) | (21) | (32) | (45) | (252) | ||
Net income (post-tax) | 648 | 102 | 135 | 351 | (104) | 1,132 | ||
Less: Net income (post-tax) attributed to | ||||||||
Non-controlling interests | 38 | - | - | 1 | - | 39 | ||
Participating policyholders | 28 | 23 | - | - | - | 51 | ||
Net income (loss) attributed to shareholders (post-tax) | 582 | 79 | 135 | 350 | (104) | 1,042 | ||
Less: Items excluded from core earnings (post-tax) | ||||||||
Market experience gains (losses) | (58) | (364) | (280) | (7) | 44 | (665) | ||
Changes in actuarial methods and assumptions that flow directly through income | - | - | - | - | - | - | ||
Restructuring charge | - | - | - | - | - | - | ||
Reinsurance transactions, tax related items and other | (7) | 41 | - | (42) | (22) | (30) | ||
Core earnings (post-tax) | $ 647 | $ 402 | $ 415 | $ 399 | $ (126) | $ 1,737 | ||
Income tax on core earnings (see above) | 64 | 107 | 95 | 46 | 8 | 320 | ||
Core earnings (pre-tax) | $ 711 | $ 509 | $ 510 | $ 445 | $ (118) | $ 2,057 | ||
Core earnings, CER basis and U.S. dollars – 2Q24
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
2Q24 | |||||||||
Asia | Canada | U.S. | Global | Corporate | Total | ||||
Core earnings (post-tax) | $ 647 | $ 402 | $ 415 | $ 399 | $ (126) | $ 1,737 | |||
CER adjustment(1) | - | - | - | - | - | - | |||
Core earnings, CER basis (post-tax) | $ 647 | $ 402 | $ 415 | $ 399 | $ (126) | $ 1,737 | |||
Income tax on core earnings, CER basis(2) | 64 | 107 | 95 | 46 | 8 | 320 | |||
Core earnings, CER basis (pre-tax) | $ 711 | $ 509 | $ 510 | $ 445 | $ (118) | $ 2,057 | |||
Core earnings (U.S. dollars) – Asia and U.S. segments | |||||||||
Core earnings (post-tax)(3), US $ | $ 472 | $ 303 | |||||||
CER adjustment US $(1) | - | - | |||||||
Core earnings, CER basis (post-tax), US $ | $ 472 | $ 303 | |||||||
(1) | The impact of updating foreign exchange rates to that which was used in 2Q24. |
(2) | Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q24. |
(3) | Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for 2Q24. |
Reconciliation of core earnings to net income attributed to shareholders – 1Q24
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
1Q24 | ||||||||
Asia | Canada | U.S. | Global | Corporate | Total | |||
Income (loss) before income taxes | $ 594 | $ 381 | $ (154) | $ 426 | $ 5 | $ 1,252 | ||
Income tax (expenses) recoveries | ||||||||
Core earnings | (67) | (91) | (103) | (58) | 33 | (286) | ||
Items excluded from core earnings | (83) | 8 | 149 | (3) | (65) | 6 | ||
Income tax (expenses) recoveries | (150) | (83) | 46 | (61) | (32) | (280) | ||
Net income (post-tax) | 444 | 298 | (108) | 365 | (27) | 972 | ||
Less: Net income (post-tax) attributed to | ||||||||
Non-controlling interests | 55 | - | - | - | - | 55 | ||
Participating policyholders | 26 | 25 | - | - | - | 51 | ||
Net income (loss) attributed to shareholders (post-tax) | 363 | 273 | (108) | 365 | (27) | 866 | ||
Less: Items excluded from core earnings (post-tax) | ||||||||
Market experience gains (losses) | (250) | (91) | (534) | 6 | 90 | (779) | ||
Changes in actuarial methods and assumptions that flow directly through income | - | - | - | - | - | - | ||
Restructuring charge | - | - | - | - | - | - | ||
Reinsurance transactions, tax related items and other | (44) | - | (26) | 2 | (41) | (109) | ||
Core earnings (post-tax) | $ 657 | $ 364 | $ 452 | $ 357 | $ (76) | $ 1,754 | ||
Income tax on core earnings (see above) | 67 | 91 | 103 | 58 | (33) | 286 | ||
Core earnings (pre-tax) | $ 724 | $ 455 | $ 555 | $ 415 | $ (109) | $ 2,040 | ||
Core earnings, CER basis and U.S. dollars – 1Q24
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
1Q24 | |||||||||
Asia | Canada | U.S. | Global | Corporate | Total | ||||
Core earnings (post-tax) | $ 657 | $ 364 | $ 452 | $ 357 | $ (76) | $ 1,754 | |||
CER adjustment(1) | 1 | - | 7 | 3 | - | 11 | |||
Core earnings, CER basis (post-tax) | $ 658 | $ 364 | $ 459 | $ 360 | $ (76) | $ 1,765 | |||
Income tax on core earnings, CER basis(2) | 67 | 91 | 104 | 58 | (33) | 287 | |||
Core earnings, CER basis (pre-tax) | $ 725 | $ 455 | $ 563 | $ 418 | $ (109) | $ 2,052 | |||
Core earnings (U.S. dollars) – Asia and U.S. segments | |||||||||
Core earnings (post-tax)(3), US $ | $ 488 | $ 335 | |||||||
CER adjustment US $(1) | (7) | - | |||||||
Core earnings, CER basis (post-tax), US $ | $ 481 | $ 335 | |||||||
(1) | The impact of updating foreign exchange rates to that which was used in 2Q24. |
(2) | Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q24. |
(3) | Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for 1Q24. |
Reconciliation of core earnings to net income attributed to shareholders – 2Q23
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
2Q23 | ||||||||
Asia | Canada | U.S. | Global | Corporate | Total | |||
Income (loss) before income taxes | $ 345 | $ 312 | $ 220 | $ 362 | $ 197 | $ 1,436 | ||
Income tax (expenses) recoveries | ||||||||
Core earnings | (73) | (97) | (110) | (45) | 18 | (307) | ||
Items excluded from core earnings | (18) | 33 | 73 | 1 | (47) | 42 | ||
Income tax (expenses) recoveries | (91) | (64) | (37) | (44) | (29) | (265) | ||
Net income (post-tax) | 254 | 248 | 183 | 318 | 168 | 1,171 | ||
Less: Net income (post-tax) attributed to | ||||||||
Non-controlling interests | 25 | - | - | 1 | - | 26 | ||
Participating policyholders | 99 | 21 | - | - | - | 120 | ||
Net income (loss) attributed to shareholders (post-tax) | 130 | 227 | 183 | 317 | 168 | 1,025 | ||
Less: Items excluded from core earnings (post-tax) | ||||||||
Market experience gains (losses) | (297) | (147) | (275) | (7) | 156 | (570) | ||
Changes in actuarial methods and assumptions that flow directly through income | - | - | - | - | - | - | ||
Restructuring charge | - | - | - | - | - | - | ||
Reinsurance transactions, tax related items and other | (46) | - | - | 4 | - | (42) | ||
Core earnings (post-tax) | $ 473 | $ 374 | $ 458 | $ 320 | $ 12 | $ 1,637 | ||
Income tax on core earnings (see above) | 73 | 97 | 110 | 45 | (18) | 307 | ||
Core earnings (pre-tax) | $ 546 | $ 471 | $ 568 | $ 365 | $ (6) | $ 1,944 | ||
Core earnings, CER basis and U.S. dollars – 2Q23
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
2Q23 | ||||||||
Asia | Canada | U.S. | Global | Corporate | Total | |||
Core earnings (post-tax) | $ 473 | $ 374 | $ 458 | $ 320 | $ 12 | $ 1,637 | ||
CER adjustment(1) | (11) | 1 | 9 | 3 | - | 2 | ||
Core earnings, CER basis (post-tax) | $ 462 | $ 375 | $ 467 | $ 323 | $ 12 | $ 1,639 | ||
Income tax on core earnings, CER basis(2) | 70 | 97 | 111 | 45 | (17) | 306 | ||
Core earnings, CER basis (pre-tax) | $ 532 | $ 472 | $ 578 | $ 368 | $ (5) | $ 1,945 | ||
Core earnings (U.S. dollars) – Asia and U.S. segments | ||||||||
Core earnings (post-tax)(3), US $ | $ 353 | $ 341 | ||||||
CER adjustment US $(1) | (16) | - | ||||||
Core earnings, CER basis (post-tax), US $ | $ 337 | $ 341 | ||||||
(1) | The impact of updating foreign exchange rates to that which was used in 2Q24. |
(2) | Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q24. |
(3) | Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for 2Q23. |
Reconciliation of core earnings to net income attributed to shareholders – YTD 2024
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
YTD 2024 | ||||||||
Asia | Canada | U.S. | Global | Corporate | Total | |||
Income (loss) before income taxes | $ 1,357 | $ 522 | $ 2 | $ 809 | $ (54) | $ 2,636 | ||
Income tax (expenses) recoveries | ||||||||
Core earnings | (131) | (198) | (198) | (104) | 25 | (606) | ||
Items excluded from core earnings | (134) | 76 | 223 | 11 | (102) | 74 | ||
Income tax (expenses) recoveries | (265) | (122) | 25 | (93) | (77) | (532) | ||
Net income (post-tax) | 1,092 | 400 | 27 | 716 | (131) | 2,104 | ||
Less: Net income (post-tax) attributed to | ||||||||
Non-controlling interests | 93 | - | - | 1 | - | 94 | ||
Participating policyholders | 54 | 48 | - | - | - | 102 | ||
Net income (loss) attributed to shareholders (post-tax) | 945 | 352 | 27 | 715 | (131) | 1,908 | ||
Less: Items excluded from core earnings (post-tax) | ||||||||
Market experience gains (losses) | (308) | (455) | (814) | (1) | 134 | (1,444) | ||
Changes in actuarial methods and assumptions that flow directly through income | - | - | - | - | - | - | ||
Restructuring charge | - | - | - | - | - | - | ||
Reinsurance transactions, tax related items and other | (51) | 41 | (26) | (40) | (63) | (139) | ||
Core earnings (post-tax) | $ 1,304 | $ 766 | $ 867 | $ 756 | $ (202) | $ 3,491 | ||
Income tax on core earnings (see above) | 131 | 198 | 198 | 104 | (25) | 606 | ||
Core earnings (pre-tax) | $ 1,435 | $ 964 | $ 1,065 | $ 860 | $ (227) | $ 4,097 | ||
Core earnings, CER basis and U.S. dollars – YTD 2024
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
YTD 2024 | |||||||||
Asia | Canada | U.S. | Global | Corporate and Other | Total | ||||
Core earnings (post-tax) | $ 1,304 | $ 766 | $ 867 | $ 756 | $ (202) | $ 3,491 | |||
CER adjustment(1) | 1 | - | 7 | 3 | - | 11 | |||
Core earnings, CER basis (post-tax) | $ 1,305 | $ 766 | $ 874 | $ 759 | $ (202) | $ 3,502 | |||
Income tax on core earnings, CER basis(2) | 131 | 198 | 199 | 104 | (25) | 607 | |||
Core earnings, CER basis (pre-tax) | $ 1,436 | $ 964 | $ 1,073 | $ 863 | $ (227) | $ 4,109 | |||
Core earnings (U.S. dollars) – Asia and U.S. segments | |||||||||
Core earnings (post-tax)(3), US $ | $ 960 | $ 638 | |||||||
CER adjustment US $(1) | (7) | - | |||||||
Core earnings, CER basis (post-tax), US $ | $ 953 | $ 638 | |||||||
(1) | The impact of updating foreign exchange rates to that which was used in 2Q24. |
(2) | Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q24. |
(3) | Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for the two respective quarters that make up 2024 year-to-date core earnings. |
Reconciliation of core earnings to net income attributed to shareholders – YTD 2023
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
YTD 2023 | |||||||
Asia | Canada | U.S. | Global | Corporate | Total | ||
Income (loss) before income taxes | $ 958 | $ 735 | $ 439 | $ 707 | $ 316 | $ 3,155 | |
Income tax (expenses) recoveries | |||||||
Core earnings | (141) | (182) | (196) | (90) | 32 | (577) | |
Items excluded from core earnings | (55) | 19 | 126 | (2) | (85) | 3 | |
Income tax (expenses) recoveries | (196) | (163) | (70) | (92) | (53) | (574) | |
Net income (post-tax) | 762 | 572 | 369 | 615 | 263 | 2,581 | |
Less: Net income (post-tax) attributed to | |||||||
Non-controlling interests | 79 | - | - | 1 | - | 80 | |
Participating policyholders | 34 | 36 | - | - | - | 70 | |
Net income (loss) attributed to shareholders (post-tax) | 649 | 536 | 369 | 614 | 263 | 2,431 | |
Less: Items excluded from core earnings (post-tax) | |||||||
Market experience gains (losses) | (267) | (191) | (441) | 2 | 262 | (635) | |
Changes in actuarial methods and assumptions that flow directly through income | - | - | - | - | - | - | |
Restructuring charge | - | - | - | - | - | - | |
Reinsurance transactions, tax related items and other | (46) | - | (33) | 5 | (28) | (102) | |
Core earnings (post-tax) | $ 962 | $ 727 | $ 843 | $ 607 | $ 29 | $ 3,168 | |
Income tax on core earnings (see above) | 141 | 182 | 196 | 90 | (32) | 577 | |
Core earnings (pre-tax) | $ 1,103 | $ 909 | $ 1,039 | $ 697 | $ (3) | $ 3,745 | |
Core earnings, CER basis and U.S. dollars – YTD 2023
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
YTD 2023 | ||||||
Asia | Canada | U.S. | Global | Corporate | Total | |
Core earnings (post-tax) | $ 962 | $ 727 | $ 843 | $ 607 | $ 29 | $ 3,168 |
CER adjustment(1) | (26) | - | 14 | 5 | 1 | (6) |
Core earnings, CER basis (post-tax) | $ 936 | $ 727 | $ 857 | $ 612 | $ 30 | $ 3,162 |
Income tax on core earnings, CER basis(2) | 135 | 182 | 198 | 90 | (31) | 574 |
Core earnings, CER basis (pre-tax) | $ 1,071 | $ 909 | $ 1,055 | $ 702 | $ (1) | $ 3,736 |
Core earnings (U.S. dollars) – Asia and U.S. segments | ||||||
Core earnings (post-tax)(3), US $ | $ 714 | $ 626 | ||||
CER adjustment US $(1) | (31) | - | ||||
Core earnings, CER basis (post-tax), US $ | $ 683 | $ 626 | ||||
(1) | The impact of updating foreign exchange rates to that which was used in 2Q24. |
(2) | Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q24. |
(3) | Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for the two respective quarters that make up 2023 year-to-date core earnings. |
Core earnings available to common shareholders
($ millions, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
Quarterly Results | YTD Results | Full Year | ||||||
2Q24 | 1Q24 | 4Q23 | 3Q23 | 2Q23 | 2024 | 2023 | 2023 | |
Core earnings | $ 1,737 | $ 1,754 | $ 1,773 | $ 1,743 | $ 1,637 | $ 3,491 | $ 3,168 | $ 6,684 |
Less: Preferred share dividends and other equity distributions | 99 | 55 | 99 | 54 | 98 | 154 | 150 | 303 |
Core earnings available to common shareholders | 1,638 | 1,699 | 1,674 | 1,689 | 1,539 | 3,337 | 3,018 | 6,381 |
CER adjustment(1) | - | 11 | (1) | 13 | 2 | 11 | (6) | 6 |
Core earnings available to common shareholders, CER basis | $ 1,638 | $ 1,710 | $ 1,673 | $ 1,702 | $ 1,541 | $ 3,348 | $ 3,012 | $ 6,387 |
(1) | The impact of updating foreign exchange rates to that which was used in 2Q24. |
Core ROE
($ millions, unless otherwise stated)
Quarterly Results | YTD Results | Full Year | ||||||
2Q24 | 1Q24 | 4Q23 | 3Q23 | 2Q23 | 2024 | 2023 | 2023 | |
Core earnings available to common shareholders | $ 1,638 | $ 1,699 | $ 1,674 | $ 1,689 | $ 1,539 | $ 3,337 | $ 3,018 | $ 6,381 |
Annualized core earnings available to common shareholders | $ 6,588 | $ 6,833 | $ 6,641 | $ 6,701 | $ 6,173 | $ 6,711 | $ 6,086 | $ 6,381 |
Average common shareholders' equity (see below) | $ 41,947 | $ 40,984 | $ 40,563 | $ 39,897 | $ 39,881 | $ 41,466 | $ 40,173 | $ 40,201 |
Core ROE (annualized) (%) | 15.7 % | 16.7 % | 16.4 % | 16.8 % | 15.5 % | 16.2 % | 15.2 % | 15.9 % |
Average common shareholders' equity | ||||||||
Total shareholders' and other equity | $ 48,965 | $ 48,250 | $ 47,039 | $ 47,407 | $ 45,707 | $ 48,965 | $ 45,707 | $ 47,039 |
Less: Preferred shares and other equity | 6,660 | 6,660 | 6,660 | 6,660 | 6,660 | 6,660 | 6,660 | 6,660 |
Common shareholders' equity | $ 42,305 | $ 41,590 | $ 40,379 | $ 40,747 | $ 39,047 | $ 42,305 | $ 39,047 | $ 40,379 |
Average common shareholders' equity | $ 41,947 | $ 40,984 | $ 40,563 | $ 39,897 | $ 39,881 | $ 41,466 | $ 40,173 | $ 40,201 |
Core earnings available to common shareholders excluding the impact of GMT
For the three months ended June 30, | |
($ millions and post-tax) | 2024 |
Core earnings available to common shareholders | $ 1,638 |
Less: GMT included in core earnings | (46) |
Core earnings available to common shareholders excluding the impact GMT | $ 1,684 |
CSM and post-tax CSM information
($ millions pre-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
As at | June 30, | Mar 31, | Dec 31, | Sept 30, | June 30, |
CSM | $ 21,760 | $ 22,075 | $ 21,301 | $ 18,149 | $ 18,103 |
Less: CSM for NCI | 1,002 | 986 | 861 | 780 | 680 |
CSM, net of NCI | $ 20,758 | $ 21,089 | $ 20,440 | $ 17,369 | $ 17,423 |
CER adjustment(1) | - | 23 | 264 | 18 | 214 |
CSM, net of NCI, CER basis | $ 20,758 | $ 21,112 | $ 20,704 | $ 17,387 | $ 17,637 |
Post-tax CSM | |||||
CSM | $ 21,760 | $ 22,075 | $ 21,301 | $ 18,149 | $ 18,103 |
Marginal tax rate on CSM | (2,576) | (2,650) | (2,798) | (2,474) | (2,645) |
Post-tax CSM | $ 19,184 | $ 19,425 | $ 18,503 | $ 15,675 | $ 15,458 |
CSM, net of NCI | $ 20,758 | $ 21,089 | $ 20,440 | $ 17,369 | $ 17,423 |
Marginal tax rate on CSM net of NCI | (2,468) | (2,542) | (2,692) | (2,377) | (2,546) |
Post-tax CSM net of NCI | $ 18,290 | $ 18,547 | $ 17,748 | $ 14,992 | $ 14,877 |
(1) | The impact of reflecting CSM and CSM net of NCI using the foreign exchange rates for the Statement of Financial Position in effect for 2Q24. |
New business CSM(1) detail, CER basis
($ millions pre-tax, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
Quarterly Results | YTD Results | Full Year | |||||||
2Q24 | 1Q24 | 4Q23 | 3Q23 | 2Q23 | 2024 | 2023 | 2023 | ||
New business CSM | |||||||||
Hong Kong | $ 200 | $ 168 | $ 199 | $ 167 | $ 191 | $ 368 | $ 310 | $ 676 | |
Japan | 90 | 48 | 42 | 29 | 19 | 138 | 55 | 126 | |
Asia Other | 188 | 275 | 173 | 206 | 222 | 463 | 368 | 747 | |
International High Net Worth | 231 | ||||||||
Mainland China | 138 | ||||||||
Singapore | 244 | ||||||||
Vietnam | 87 | ||||||||
Other Emerging Markets | 47 | ||||||||
Asia | 478 | 491 | 414 | 402 | 432 | 969 | 733 | 1,549 | |
Canada | 76 | 70 | 70 | 51 | 57 | 146 | 103 | 224 | |
U.S. | 74 | 97 | 142 | 54 | 103 | 171 | 198 | 394 | |
Total new business CSM | $ 628 | $ 658 | $ 626 | $ 507 | $ 592 | $ 1,286 | $ 1,034 | $ 2,167 | |
New business CSM, CER adjustment(2),(3) | |||||||||
Hong Kong | $ - | $ 2 | $ 2 | $ 4 | $ 4 | $ 2 | $ 5 | $ - | |
Japan | - | (1) | (3) | (2) | (2) | (1) | (7) | (8) | |
Asia Other | - | 2 | - | 3 | - | 2 | (4) | (5) | |
International High Net Worth | 1 | ||||||||
Mainland China | (1) | ||||||||
Singapore | - | ||||||||
Vietnam | (4) | ||||||||
Other Emerging Markets | (1) | ||||||||
Asia | - | 3 | (1) | 5 | 2 | 3 | (6) | (13) | |
Canada | - | - | (1) | 1 | (1) | - | (1) | - | |
U.S. | - | 2 | 1 | 1 | 1 | 2 | 3 | (1) | |
Total new business CSM | $ - | $ 5 | $ (1) | $ 7 | $ 2 | $ 5 | $ (4) | $ (14) | |
New business CSM, CER basis | |||||||||
Hong Kong | $ 200 | $ 170 | $ 201 | $ 171 | $ 195 | $ 370 | $ 315 | $ 676 | |
Japan | 90 | 47 | 39 | 27 | 17 | 137 | 48 | 118 | |
Asia Other | 188 | 277 | 173 | 209 | 222 | 465 | 364 | 742 | |
International High Net Worth | 232 | ||||||||
Mainland China | 137 | ||||||||
Singapore | 244 | ||||||||
Vietnam | 83 | ||||||||
Other Emerging Markets | 46 | ||||||||
Asia | 478 | 494 | 413 | 407 | 434 | 972 | 727 | 1,536 | |
Canada | 76 | 70 | 69 | 52 | 56 | 146 | 102 | 224 | |
U.S. | 74 | 99 | 143 | 55 | 104 | 173 | 201 | 393 | |
Total new business CSM, CER basis | $ 628 | $ 663 | $ 625 | $ 514 | $ 594 | $ 1,291 | $ 1,030 | $ 2,153 | |
(1) | New business CSM is net of NCI. |
(2) | The impact of updating foreign exchange rates to that which was used in 2Q24. |
(3) | New business CSM for Asia Other is reported by country annually, on a full year basis. Other Emerging Markets within Asia Other include Indonesia, the Philippines, Malaysia, Thailand, Cambodia and Myanmar. |
Net income financial measures on a CER basis
($ Canadian millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
Quarterly Results | YTD Results | Full Year | ||||||
2Q24 | 1Q24 | 4Q23 | 3Q23 | 2Q23 | 2024 | 2023 | 2023 | |
Net income (loss) attributed to shareholders: | ||||||||
Asia | $ 582 | $ 363 | $ 615 | $ 84 | $ 130 | $ 945 | $ 649 | $ 1,348 |
Canada | 79 | 273 | 365 | 290 | 227 | 352 | 536 | 1,191 |
U.S. | 135 | (108) | 198 | 72 | 183 | 27 | 369 | 639 |
Global WAM | 350 | 365 | 365 | 318 | 317 | 715 | 614 | 1,297 |
Corporate and Other | (104) | (27) | 116 | 249 | 168 | (131) | 263 | 628 |
Total net income (loss) attributed to shareholders | 1,042 | 866 | 1,659 | 1,013 | 1,025 | 1,908 | 2,431 | 5,103 |
Preferred share dividends and other equity distributions | (99) | (55) | (99) | (54) | (98) | (154) | (150) | (303) |
Common shareholders' net income (loss) | $ 943 | $ 811 | $ 1,560 | $ 959 | $ 927 | $ 1,754 | $ 2,281 | $ 4,800 |
CER adjustment(1) | ||||||||
Asia | $ - | $ 4 | $ 10 | $ 5 | $ 20 | $ 4 | $ 23 | $ 38 |
Canada | - | 2 | (2) | 1 | 2 | 2 | (1) | (2) |
U.S. | - | (2) | - | - | 15 | (2) | 17 | 17 |
Global WAM | - | 4 | 1 | 5 | 5 | 4 | 6 | 12 |
Corporate and Other | - | 2 | 1 | (2) | (16) | 2 | (19) | (20) |
Total net income (loss) attributed to shareholders | - | 10 | 10 | 9 | 26 | 10 | 26 | 45 |
Preferred share dividends and other equity distributions | - | - | - | - | - | - | - | - |
Common shareholders' net income (loss) | $ - | $ 10 | $ 10 | $ 9 | $ 26 | $ 10 | $ 26 | $ 45 |
Net income (loss) attributed to shareholders, CER basis | ||||||||
Asia | $ 582 | $ 367 | $ 625 | $ 89 | $ 150 | $ 949 | $ 672 | $ 1,386 |
Canada | 79 | 275 | 363 | 291 | 229 | 354 | 535 | 1,189 |
U.S. | 135 | (110) | 198 | 72 | 198 | 25 | 386 | 656 |
Global WAM | 350 | 369 | 366 | 323 | 322 | 719 | 620 | 1,309 |
Corporate and Other | (104) | (25) | 117 | 247 | 152 | (129) | 244 | 608 |
Total net income (loss) attributed to shareholders, CER basis | 1,042 | 876 | 1,669 | 1,022 | 1,051 | 1,918 | 2,457 | 5,148 |
Preferred share dividends and other equity distributions, CER basis | (99) | (55) | (99) | (54) | (98) | (154) | (150) | (303) |
Common shareholders' net income (loss), CER basis | $ 943 | $ 821 | $ 1,570 | $ 968 | $ 953 | $ 1,764 | $ 2,307 | $ 4,845 |
Asia net income attributed to shareholders, U.S. dollars | ||||||||
Asia net income (loss) attributed to shareholders, US $(2) | $ 424 | $ 270 | $ 452 | $ 63 | $ 96 | $ 694 | $ 480 | $ 995 |
CER adjustment, US $(1) | - | (2) | 5 | 1 | 13 | (2) | 10 | 16 |
Asia net income (loss) attributed to shareholders, U.S. $, CER basis(1) | $ 424 | $ 268 | $ 457 | $ 64 | $ 109 | $ 692 | $ 490 | $ 1,011 |
(1) | The impact of updating foreign exchange rates to that which was used in 2Q24. |
(2) | Asia net income attributed to shareholders (post-tax) in Canadian dollars is translated to U.S. dollars using the U.S. dollar Statement of Income rate for the respective reporting period. |
Adjusted book value
As at ($ millions) | June 30, | Mar 31, | Dec 31, | Sept 30, | June 30, |
Common shareholders' equity | $ 42,305 | $ 41,590 | $ 40,379 | $ 40,747 | $ 39,047 |
Post-tax CSM, net of NCI | 18,290 | 18,547 | 17,748 | 14,992 | 14,877 |
Adjusted book value | $ 60,595 | $ 60,137 | $ 58,127 | $ 55,739 | $ 53,924 |
Reconciliation of Global WAM core earnings to core EBITDA
($ millions, pre-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
Quarterly Results | YTD Results | Full Year | ||||||
2Q24 | 1Q24 | 4Q23 | 3Q23 | 2Q23 | 2024 | 2023 | 2023 | |
Global WAM core earnings (post-tax) | $ 399 | $ 357 | $ 353 | $ 361 | $ 320 | $ 756 | $ 607 | $ 1,321 |
Add back taxes, acquisition costs, other expenses and deferred sales commissions | ||||||||
Core income tax (expenses) recoveries (see above) | 46 | 58 | 55 | 59 | 45 | 104 | 90 | 204 |
Amortization of deferred acquisition costs and other depreciation | 49 | 42 | 45 | 41 | 40 | 91 | 80 | 166 |
Amortization of deferred sales commissions | 19 | 20 | 21 | 19 | 19 | 39 | 40 | 80 |
Core EBITDA | $ 513 | $ 477 | $ 474 | $ 480 | $ 424 | $ 990 | $ 817 | $ 1,771 |
CER adjustment(1) | - | 5 | - | 6 | 4 | 5 | 5 | 11 |
Core EBITDA, CER basis | $ 513 | $ 482 | $ 474 | $ 486 | $ 428 | $ 995 | $ 822 | $ 1,782 |
(1) | The impact of updating foreign exchange rates to that which was used in 2Q24. |
Core EBITDA margin and core revenue
Quarterly Results | YTD Results | Full Year | ||||||
($ millions, unless otherwise stated) | 2Q24 | 1Q24 | 4Q23 | 3Q23 | 2Q23 | 2024 | 2023 | 2023 |
Core EBITDA margin | ||||||||
Core EBITDA | $ 513 | $ 477 | $ 474 | $ 480 | $ 424 | $ 990 | $ 817 | $ 1,771 |
Core revenue | $ 1,948 | $ 1,873 | $ 1,842 | $ 1,783 | $ 1,722 | $ 3,821 | $ 3,478 | $ 7,103 |
Core EBITDA margin | 26.3 % | 25.5 % | 25.7 % | 26.9 % | 24.6 % | 25.9 % | 23.5 % | 24.9 % |
Global WAM core revenue | ||||||||
Other revenue per financial statements | $ 1,849 | $ 1,808 | $ 1,719 | $ 1,645 | $ 1,691 | $ 3,657 | $ 3,382 | $ 6,746 |
Less: Other revenue in segments other than Global WAM | 40 | 58 | 31 | (64) | 44 | 98 | 70 | 37 |
Other revenue in Global WAM (fee income) | $ 1,809 | $ 1,750 | $ 1,688 | $ 1,709 | $ 1,647 | $ 3,559 | $ 3,312 | $ 6,709 |
Investment income per financial statements | $ 4,261 | $ 4,251 | $ 4,497 | $ 4,028 | $ 4,135 | $ 8,512 | $ 7,655 | $ 16,180 |
Realized and unrealized gains (losses) on assets supporting | 564 | 538 | 2,674 | (2,430) | 950 | 1,102 | 2,894 | 3,138 |
Total investment income | 4,825 | 4,789 | 7,171 | 1,598 | 5,085 | 9,614 | 10,549 | 19,318 |
Less: Investment income in segments other than Global WAM | 4,687 | 4,649 | 6,941 | 1,578 | 5,010 | 9,336 | 10,367 | 18,886 |
Investment income in Global WAM | $ 138 | $ 140 | $ 230 | $ 20 | $ 75 | $ 278 | $ 182 | $ 432 |
Total other revenue and investment income in Global WAM | $ 1,947 | $ 1,890 | $ 1,918 | $ 1,729 | $ 1,722 | $ 3,837 | $ 3,494 | $ 7,141 |
Less: Total revenue reported in items excluded from core earnings | ||||||||
Market experience gains (losses) | (9) | 8 | 63 | (54) | 7 | (1) | 19 | 28 |
Revenue related to integration and acquisitions | 8 | 9 | 13 | - | (7) | 17 | (3) | 10 |
Global WAM core revenue | $ 1,948 | $ 1,873 | $ 1,842 | $ 1,783 | $ 1,722 | $ 3,821 | $ 3,478 | $ 7,103 |
CAUTION REGARDING FORWARD-LOOKING STATEMENTS:
From time to time, Manulife makes written and/or oral forward-looking statements, including in this document. In addition, our representatives may make forward-looking statements orally to analysts, investors, the media and others. All such statements are made pursuant to the "safe harbour" provisions of Canadian provincial securities laws and the U.S. Private Securities Litigation Reform Act of 1995.
The forward-looking statements in this document include, but are not limited to, statements with respect to our ability to achieve our medium-term financial and operating targets and planned common share buybacks, and also relate to, among other things, our objectives, goals, strategies, intentions, plans, beliefs, expectations and estimates, and can generally be identified by the use of words such as "may", "will", "could", "should", "would", "likely", "suspect", "outlook", "expect", "intend", "estimate", "anticipate", "believe", "plan", "forecast", "objective", "seek", "aim", "continue", "goal", "restore", "embark" and "endeavour" (or the negative thereof) and words and expressions of similar import, and include statements concerning possible or assumed future results. Although we believe that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements and they should not be interpreted as confirming market or analysts' expectations in any way.
Certain material factors or assumptions are applied in making forward-looking statements and actual results may differ materially from those expressed or implied in such statements.
Important factors that could cause actual results to differ materially from expectations include but are not limited to: general business and economic conditions (including but not limited to the performance, volatility and correlation of equity markets, interest rates, credit and swap spreads, inflation rates, currency rates, investment losses and defaults, market liquidity and creditworthiness of guarantors, reinsurers and counterparties); the ongoing prevalence of COVID-19, including any variants, as well as actions that have been, or may be taken by governmental authorities in response to COVID-19, including the impacts of any variants; changes in laws and regulations; changes in accounting standards applicable in any of the territories in which we operate; changes in regulatory capital requirements; our ability to obtain premium rate increases on in-force policies; our ability to execute strategic plans and changes to strategic plans; downgrades in our financial strength or credit ratings; our ability to maintain our reputation; impairments of goodwill or intangible assets or the establishment of provisions against future tax assets; the accuracy of estimates relating to morbidity, mortality and policyholder behaviour; the accuracy of other estimates used in applying accounting policies, actuarial methods and embedded value methods; our ability to implement effective hedging strategies and unforeseen consequences arising from such strategies; our ability to source appropriate assets to back our long-dated liabilities; level of competition and consolidation; our ability to market and distribute products through current and future distribution channels; unforeseen liabilities or asset impairments arising from acquisitions and dispositions of businesses; the realization of losses arising from the sale of investments classified fair value through other comprehensive income; our liquidity, including the availability of financing to satisfy existing financial liabilities on expected maturity dates when required; obligations to pledge additional collateral; the availability of letters of credit to provide capital management flexibility; accuracy of information received from counterparties and the ability of counterparties to meet their obligations; the availability, affordability and adequacy of reinsurance; legal and regulatory proceedings, including tax audits, tax litigation or similar proceedings; our ability to adapt products and services to the changing market; our ability to attract and retain key executives, employees and agents; the appropriate use and interpretation of complex models or deficiencies in models used; political, legal, operational and other risks associated with our non-North American operations; geopolitical uncertainty, including international conflicts; acquisitions and our ability to complete acquisitions including the availability of equity and debt financing for this purpose; the disruption of or changes to key elements of the Company's or public infrastructure systems; environmental concerns, including climate change; our ability to protect our intellectual property and exposure to claims of infringement; and our inability to withdraw cash from subsidiaries and the fact that the amount and timing of any future common share repurchases will depend on the earnings, cash requirements and financial condition of Manulife, market conditions, capital requirements (including under LICAT capital standards), common share issuance requirements, applicable law and regulations (including Canadian and U.S. securities laws and Canadian insurance company regulations), and other factors deemed relevant by Manulife, and may be subject to regulatory approval or conditions.
Additional information about material risk factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements may be found under "Risk Management and Risk Factors" and "Critical Actuarial and Accounting Policies" in the Management's Discussion and Analysis in our most recent annual report, under "Risk Management and Risk Factors Update" and "Critical Actuarial and Accounting Policies" in the Management's Discussion and Analysis in our most recent interim report, and in the "Risk Management" note to the Consolidated Financial Statements in our most recent annual and interim reports, as well as elsewhere in our filings with Canadian and U.S. securities regulators.
The forward-looking statements in this document are, unless otherwise indicated, stated as of the date hereof and are presented for the purpose of assisting investors and others in understanding our financial position and results of operations, our future operations, as well as our objectives and strategic priorities, and may not be appropriate for other purposes. We do not undertake to update any forward-looking statements, except as required by law.
SOURCE Manulife Financial Corporation
Share this article